Table 3.
Predicting future intention to test for prostate cancer* | |||||
---|---|---|---|---|---|
B | SE B | CI lower | CI upper | p Value | |
Constant | −0.11 | 1.51 | −3.25 | 3.03 | 0.944 |
Preassessment intention to test score | 0.72 | 0.16 | 0.38 | 1.06 | 0.000 |
How many times tested previously | 0.66 | 0.19 | 0.26 | 1.06 | 0.003 |
Group membership (jury/control) | −4.31 | 1.09 | −6.58 | −2.04 | 0.001 |
Note. N=25.
*As it was anticipated that men who had been tested for prostate cancer previously would be more likely to continue with this course of action, group differences in intention to be tested for prostate cancer in the future were examined using linear regression, adjusting for baseline future intention to test, the number of times a man had a prostate-specific antigen test at baseline, and his group membership.